infliximab treatment

BIOLOGICAL2 trials

Sponsors

Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Xijing Hospital of Digestive Diseases

Conditions

Kawasaki diseaseRectal UlcerUlcerative Colitis Chronic ModerateUlcerative Colitis Chronic Severe

Phase 1

Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers

Xijing Hospital of Digestive DiseasesRectal Ulcer, Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe

Start: 2023-07-01End: 2025-12-31Target: 60Updated: 2023-06-22

Unknown Phase

Infliximab(anti human TNF alfa monoclonal antibody, Remicade) off-label treatment for refractory Kawasaki disease

Active, not recruitingJPRN-UMIN000007423

Department of Pediatrics, Saitama Medical Center, Saitama Medical UniversityKawasaki disease

Start: 2012-03-01Target: 5Updated: 2026-06-29